These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. New drug found active against lung cancers. Hospitals; 1982 Jun; 56(12):38. PubMed ID: 7042515 [No Abstract] [Full Text] [Related]
63. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798 [TBL] [Abstract][Full Text] [Related]
64. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study. Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701 [TBL] [Abstract][Full Text] [Related]
65. Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology Group. Blum RH; Edmonson J; Ryan L; Pelletier L Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S238-40. PubMed ID: 8453706 [TBL] [Abstract][Full Text] [Related]
67. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States. Pratt CB Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456 [TBL] [Abstract][Full Text] [Related]
68. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma. Cabanillas F; Rodriguez V; Bodey GP Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634 [No Abstract] [Full Text] [Related]
69. A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults. Harstrick A; Bokemeyer C; Schmoll HJ; Köhne-Wömpner CH; Knipp H; Schöffski P; Anagnou J; Wipperman B; Neumann S; Poliwoda H Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S217-21. PubMed ID: 8453702 [TBL] [Abstract][Full Text] [Related]
70. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)]. Teufel G; Pfleiderer A Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795 [TBL] [Abstract][Full Text] [Related]
71. Ifosfamide: an old drug recently rediscovered. Cavalli F Eur J Cancer Clin Oncol; 1988 Jun; 24(6):959-61. PubMed ID: 3409945 [No Abstract] [Full Text] [Related]
72. Ifosfamide combination regimens for soft-tissue sarcoma. Stuart-Harris R; Dalley D; Bell DR; Levi J; Simes RJ; Wiltshaw E Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695 [TBL] [Abstract][Full Text] [Related]
73. Trofosfamide in the palliative treatment of cancer: a review of the literature. Latz D; Nassar N; Frank R Onkologie; 2004 Dec; 27(6):572-6. PubMed ID: 15591719 [TBL] [Abstract][Full Text] [Related]
74. Ifosfamide in the treatment of soft tissue sarcomas. Connelly EF; Budd GT Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442 [TBL] [Abstract][Full Text] [Related]
75. Cis-platinum in the treatment of testicular and other cancers. Williams SD; Einhorn LH Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553 [No Abstract] [Full Text] [Related]
76. [Clinical efficacy of four-drug combination treatment of adriamycin, vincristine, ifosfamide, and prednisolone for patients with malignant lymphoma, especially relapsed or refractory types (author's transl)]. Kimura I; Ohnoshi T; Oka A; Nakata Y; Hayashi K; Sato M; Nishihara R; Tanaka T; Sezaki T Rinsho Ketsueki; 1980 Jun; 21(6):785-91. PubMed ID: 7463736 [No Abstract] [Full Text] [Related]
77. Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724). Nelson RL; Creaven PJ; Cohen MH; Fossieck BE Eur J Cancer (1965); 1976 Mar; 12(3):195-8. PubMed ID: 780113 [No Abstract] [Full Text] [Related]
78. Role of antitumor antibiotics in current oncologic practice. Davis HL; von Hoff DD; Henney JE; Rozencweig M Recent Results Cancer Res; 1978; 63():21-9. PubMed ID: 212796 [TBL] [Abstract][Full Text] [Related]
79. Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial. Carter SK J Natl Cancer Inst; 1976 Aug; 57(2):235-44. PubMed ID: 794496 [No Abstract] [Full Text] [Related]